The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage? Response

    Research output: Contribution to journalLetterpeer-review

    Original languageEnglish
    Pages (from-to)228-228
    Number of pages1
    JournalHeart
    Volume96
    Issue number3
    DOIs
    Publication statusPublished - Feb 2010

    Keywords

    • INTERVENTIONAL STRATEGY
    • RANDOMIZED-TRIAL

    Cite this